UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
Clinical trial NCT03158883 · COMPLETED
Trial details
- NCT number
- NCT03158883
- Sponsor
- Megan Daly, MD
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2020-04-09
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.